Document Detail


Pregnancy and oral contraceptives in factor V deficiency: a study of 22 patients (five homozygotes and 17 heterozygotes) and review of the literature.
MedLine Citation:
PMID:  15660985     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Information on the effect of pregnancy or oral contraceptives (OC) in congenital factor V (FV) deficiency is scanty. The personal investigation of five homozygous and 17 female heterozygous showed that patients with severe deficiency bleed considerably at the time of delivery. However, bleeding can be controlled properly by administration of fresh frozen plasma with excellent foetal outcome. The safe level for adequate haemostasis seems around 25% of normal. On the contrary, heterozygote patients show no significant postpartum bleeding and therefore need no substitution therapy. Oral contraceptives were taken and well tolerated by four of our homozygous patients and appear to be beneficial because they cause a decrease in menometrorrhagies thereby improving the anaemia and decreasing transfusional needs. One patient took hormonal replacement therapy with no undue effects. No thrombosis was noted in the propositae during oral contraceptive therapy. The review of the literature has allowed the gathering of information on 20 additional pregnancies. The foetal outcome was satisfactory in every instance. Excessive bleeding was noted in 11 pregnancies. In seven of the remaining pregnancies, no undue bleeding was noted thanks to appropriate substitution therapy. In the remaining two pregnancies no bleeding was noted and no substitution therapy was given. No data are apparently available in the literature about the use of OCs in FV deficiency.
Authors:
A Girolami; R Scandellari; A M Lombardi; B Girolami; E Bortoletto; E Zanon
Related Documents :
6174375 - Early pregnancy factor as a monitor for fertilization in women wearing intrauterine dev...
10023095 - Emergency contraception: change in knowledge of women attending for termination of preg...
15327615 - A prospective study of pregravid oral contraceptive use in relation to fetal growth.
22628185 - Major, non-chromosomal, birth defects and maternal physical activity: a systematic review.
15828945 - Collagen in the scarless fetal skin wound: detection with picrosirius-polarization.
18855315 - The role of the pediatric surgeon in the perinatal multidisciplinary team.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Haemophilia : the official journal of the World Federation of Hemophilia     Volume:  11     ISSN:  1351-8216     ISO Abbreviation:  Haemophilia     Publication Date:  2005 Jan 
Date Detail:
Created Date:  2005-01-21     Completed Date:  2005-05-25     Revised Date:  2009-10-21    
Medline Journal Info:
Nlm Unique ID:  9442916     Medline TA:  Haemophilia     Country:  England    
Other Details:
Languages:  eng     Pagination:  26-30     Citation Subset:  IM    
Affiliation:
Department of Medical and Surgical Sciences, University of Padua Medical School, Padua, Italy. antonio.girolami@unipd.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Transfusion
Contraceptives, Oral, Hormonal*
Factor V Deficiency*
Female
Heterozygote
Homozygote
Humans
Plasma
Postpartum Hemorrhage / therapy
Pregnancy
Pregnancy Complications, Hematologic*
Pregnancy Outcome
Chemical
Reg. No./Substance:
0/Contraceptives, Oral, Hormonal
Comments/Corrections
Comment In:
Haemophilia. 2005 Jul;11(4):422-3   [PMID:  16011601 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of factor XI inhibitor using recombinant activated factor VIIa.
Next Document:  Molecular characterization of two novel mutations causing factor X deficiency in a Chinese pedigree.